BioMark Diagnostics Inc. (BUX.CN)
CAD 0.2
(0.0%)
CAD 0.2
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 163.22 Thousand | 153.49 Thousand | 43.93 Thousand | - | 263.28 Thousand | - |
| Cost of Revenue | - | 386.19 Thousand | - | 13.68 Thousand | - | - |
| Gross Profit | 163.22 Thousand | -232.7 Thousand | 43.93 Thousand | -13.68 Thousand | 263.28 Thousand | - |
| Operating Expenses | 1.47 Million | 1.88 Million | 1.44 Million | 1.07 Million | 1.47 Million | 545.61 Thousand |
| Selling, General and Administrative Expenses | 828.36 Thousand | 1.15 Million | 863.85 Thousand | 961.47 Thousand | 1.41 Million | 489.18 Thousand |
| Research and Development Expenses | 650.53 Thousand | 545.84 Thousand | 497.77 Thousand | 118.43 Thousand | 42.34 Thousand | 56.43 Thousand |
| Other Expenses | - | - | 85.4 Thousand | 2737.00 | 11.9 Thousand | - |
| Cost and Expenses | 1.47 Million | 1.88 Million | 1.44 Million | 1.09 Million | 1.47 Million | 545.61 Thousand |
| Operating Income | -1.31 Million | -1.84 Million | -1.28 Million | -1.09 Million | -1.18 Million | -545.61 Thousand |
| Interest Expense | 115.16 Thousand | 110.23 Thousand | 49.68 Thousand | 4138.00 | 2265.00 | - |
| Income Tax Expense | -193.49 Thousand | 108.29 Thousand | 49.68 Thousand | 4.00 | 6237.00 | -18.75 Thousand |
| Earnings before Tax | -1.62 Million | -1.84 Million | -1.45 Million | -1.09 Million | -1.21 Million | -545.61 Thousand |
| Net Income | -1.42 Million | -1.84 Million | -1.45 Million | -1.09 Million | -1.21 Million | -545.61 Thousand |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
| Weighted Average Shares Outstanding | 85.23 Million | 82.77 Million | 72.31 Million | 73.3 Million | 71.29 Million | 65.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 85.23 Million | 82.77 Million | 72.31 Million | 73.3 Million | 71.29 Million | 65.91 Million |
| Gross Margin | 1.00 | -1.52 | 1.00 | - | 1.00 | - |
| EBIT Margin | -6.82 | -8.77 | -27.85 | - | -4.52 | - |
| Profit Margin | -8.75 | -12.00 | -33.09 | - | -4.62 | - |
| EBITDA | -1.11 Million | -1.34 Million | -1.22 Million | -1.07 Million | -1.2 Million | -18.75 Thousand |
| Earnings Before Tax Margin | -8.06 | -11.99 | -29.23 | - | -4.49 | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 38.31 Thousand | 39.8 Thousand | 163.22 Thousand | 41.54 Thousand | 42.12 Thousand | 39.74 Thousand |
| Cost of Revenue | 57.75 Thousand | 100.84 Thousand | 393.17 Thousand | 99.3 Thousand | 90.51 Thousand | 102.5 Thousand |
| Gross Profit | -19.44 Thousand | -61.04 Thousand | -229.95 Thousand | -57.76 Thousand | -48.38 Thousand | -62.75 Thousand |
| Operating Expenses | 642.61 Thousand | 436.2 Thousand | 1.57 Million | 383.04 Thousand | 428.37 Thousand | 433.29 Thousand |
| Selling, General and Administrative Expenses | 347.23 Thousand | 224.91 Thousand | - | 197.94 Thousand | 229.51 Thousand | 161.55 Thousand |
| Research and Development Expenses | 182.15 Thousand | 211.28 Thousand | - | 185.1 Thousand | 94.48 Thousand | 159.65 Thousand |
| Other Expenses | 113.21 Thousand | - | - | - | - | - |
| Cost and Expenses | 642.61 Thousand | 537.04 Thousand | 1.96 Million | 482.35 Thousand | 428.37 Thousand | 433.29 Thousand |
| Operating Income | -604.3 Thousand | -497.24 Thousand | -1.8 Million | -440.81 Thousand | -386.25 Thousand | -412.96 Thousand |
| Interest Expense | 18.97 Thousand | 47.9 Thousand | 115.16 Thousand | 20.07 Thousand | 21.88 Thousand | 25.3 Thousand |
| Income Tax Expense | - | 1.00 | -193.49 Thousand | 4.00 | 18.34 Thousand | 19.41 Thousand |
| Earnings before Tax | -623.27 Thousand | -391.3 Thousand | -1.62 Million | -406.76 Thousand | -214 Thousand | -418.85 Thousand |
| Net Income | -623.27 Thousand | -391.3 Thousand | -1.42 Million | -406.76 Thousand | -210.46 Thousand | -418.85 Thousand |
| Earnings Per Share Basic | -0.01 | -0.00 | - | -0.00 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.00 | - | -0.00 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 90.88 Million | 90.88 Million | 85.23 Million | 85.23 Million | 83.28 Million | 83.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 90.88 Million | 90.88 Million | 85.23 Million | 85.23 Million | 83.28 Million | 83.28 Million |
| Gross Margin | -0.51 | -1.53 | -1.41 | -1.39 | -1.15 | -1.58 |
| EBIT Margin | -14.27 | -9.96 | - | -8.22 | -7.02 | -7.32 |
| Profit Margin | -16.27 | -9.83 | -8.75 | -9.79 | -5.00 | -10.54 |
| EBITDA | -546.54 Thousand | -396.39 Thousand | - | -341.5 Thousand | -295.73 Thousand | -290.77 Thousand |
| Earnings Before Tax Margin | -15.77 | -12.49 | -11.07 | -10.61 | -9.17 | -10.39 |
GR
BKSC
PGOL
JYOTHYLAB
TSUKY
TGKB